These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 24522233)

  • 1. Functional analysis of single cells identifies a rare subset of circulating tumor cells with malignant traits.
    Yao X; Choudhury AD; Yamanaka YJ; Adalsteinsson VA; Gierahn TM; Williamson CA; Lamb CR; Taplin ME; Nakabayashi M; Chabot MS; Li T; Lee GS; Boehm JS; Kantoff PW; Hahn WC; Wittrup KD; Love JC
    Integr Biol (Camb); 2014 Apr; 6(4):388-98. PubMed ID: 24522233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-cell analysis of circulating tumor cells identifies cumulative expression patterns of EMT-related genes in metastatic prostate cancer.
    Chen CL; Mahalingam D; Osmulski P; Jadhav RR; Wang CM; Leach RJ; Chang TC; Weitman SD; Kumar AP; Sun L; Gaczynska ME; Thompson IM; Huang TH
    Prostate; 2013 Jun; 73(8):813-26. PubMed ID: 23280481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations between AR-V7 status in circulating tumour cells, circulating tumour cell count and survival in men with metastatic castration-resistant prostate cancer.
    Belderbos BPS; Sieuwerts AM; Hoop EO; Mostert B; Kraan J; Hamberg P; Van MN; Beaufort CM; Onstenk W; van Soest RJ; Martens J; Sleijfer S; de Wit R; Mathijssen RHJ; Lolkema MP
    Eur J Cancer; 2019 Nov; 121():48-54. PubMed ID: 31542641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical phenotypes associated with circulating tumor cell enumeration in metastatic castration-resistant prostate cancer.
    Bitting RL; Healy P; Halabi S; George DJ; Goodin M; Armstrong AJ
    Urol Oncol; 2015 Mar; 33(3):110.e1-9. PubMed ID: 25595577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased adhesiveness, resistance to anoikis and suppression of GRP94 are integral to the survival of circulating tumor cells in prostate cancer.
    Howard EW; Leung SC; Yuen HF; Chua CW; Lee DT; Chan KW; Wang X; Wong YC
    Clin Exp Metastasis; 2008; 25(5):497-508. PubMed ID: 18340425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of a novel circulating tumor DNA next-generating sequencing platform with circulating tumor cells (CTCs) and CTC clusters in metastatic breast cancer.
    Davis AA; Zhang Q; Gerratana L; Shah AN; Zhan Y; Qiang W; Finkelman BS; Flaum L; Behdad A; Gradishar WJ; Platanias LC; Cristofanilli M
    Breast Cancer Res; 2019 Dec; 21(1):137. PubMed ID: 31801599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection and Characterization of Circulating Tumor Associated Cells in Metastatic Breast Cancer.
    Mu Z; Benali-Furet N; Uzan G; Znaty A; Ye Z; Paolillo C; Wang C; Austin L; Rossi G; Fortina P; Yang H; Cristofanilli M
    Int J Mol Sci; 2016 Sep; 17(10):. PubMed ID: 27706044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection and characterization of invasive circulating tumor cells derived from men with metastatic castration-resistant prostate cancer.
    Friedlander TW; Ngo VT; Dong H; Premasekharan G; Weinberg V; Doty S; Zhao Q; Gilbert EG; Ryan CJ; Chen WT; Paris PL
    Int J Cancer; 2014 May; 134(10):2284-93. PubMed ID: 24166007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of isolated circulating tumor cells and tissue biopsies using whole-genome sequencing in prostate cancer.
    Jiang R; Lu YT; Ho H; Li B; Chen JF; Lin M; Li F; Wu K; Wu H; Lichterman J; Wan H; Lu CL; OuYang W; Ni M; Wang L; Li G; Lee T; Zhang X; Yang J; Rettig M; Chung LW; Yang H; Li KC; Hou Y; Tseng HR; Hou S; Xu X; Wang J; Posadas EM
    Oncotarget; 2015 Dec; 6(42):44781-93. PubMed ID: 26575023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multigene model for predicting metastatic prostate cancer using circulating tumor cells by microfluidic magnetophoresis.
    Cho H; Chung JI; Kim J; Seo WI; Lee CH; Morgan TM; Byun SS; Chung JS; Han KH
    Cancer Sci; 2021 Feb; 112(2):859-870. PubMed ID: 33232539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Jinfukang regulates integrin/Src pathway and anoikis mediating circulating lung cancer cells migration.
    Que ZJ; Yang Y; Liu HT; Shang-Guan WJ; Yu P; Zhu LH; Li HG; Liu HM; Tian JH
    J Ethnopharmacol; 2021 Mar; 267():113473. PubMed ID: 33068649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. mRNA-Seq of single prostate cancer circulating tumor cells reveals recapitulation of gene expression and pathways found in prostate cancer.
    Cann GM; Gulzar ZG; Cooper S; Li R; Luo S; Tat M; Stuart S; Schroth G; Srinivas S; Ronaghi M; Brooks JD; Talasaz AH
    PLoS One; 2012; 7(11):e49144. PubMed ID: 23145101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limited prognostic value of preoperative circulating tumor cells for early biochemical recurrence in patients with localized prostate cancer.
    Meyer CP; Pantel K; Tennstedt P; Stroelin P; Schlomm T; Heinzer H; Riethdorf S; Steuber T
    Urol Oncol; 2016 May; 34(5):235.e11-6. PubMed ID: 26795608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumorigenic potential of circulating prostate tumor cells.
    Carvalho FL; Simons BW; Antonarakis ES; Rasheed Z; Douglas N; Villegas D; Matsui W; Berman DM
    Oncotarget; 2013 Mar; 4(3):413-21. PubMed ID: 23530114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of live circulating tumor cells by a class of near-infrared heptamethine carbocyanine dyes in patients with localized and metastatic prostate cancer.
    Shao C; Liao CP; Hu P; Chu CY; Zhang L; Bui MH; Ng CS; Josephson DY; Knudsen B; Tighiouart M; Kim HL; Zhau HE; Chung LW; Wang R; Posadas EM
    PLoS One; 2014; 9(2):e88967. PubMed ID: 24551200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional phenotyping and genotyping of circulating tumor cells from patients with castration resistant prostate cancer.
    Paris PL; Kobayashi Y; Zhao Q; Zeng W; Sridharan S; Fan T; Adler HL; Yera ER; Zarrabi MH; Zucker S; Simko J; Chen WT; Rosenberg J
    Cancer Lett; 2009 May; 277(2):164-73. PubMed ID: 19162393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased expression of apoptosis inhibitor protein XIAP contributes to anoikis resistance of circulating human prostate cancer metastasis precursor cells.
    Berezovskaya O; Schimmer AD; Glinskii AB; Pinilla C; Hoffman RM; Reed JC; Glinsky GV
    Cancer Res; 2005 Mar; 65(6):2378-86. PubMed ID: 15781653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of ERG, AR and PTEN gene status in circulating tumor cells from patients with castration-resistant prostate cancer.
    Attard G; Swennenhuis JF; Olmos D; Reid AH; Vickers E; A'Hern R; Levink R; Coumans F; Moreira J; Riisnaes R; Oommen NB; Hawche G; Jameson C; Thompson E; Sipkema R; Carden CP; Parker C; Dearnaley D; Kaye SB; Cooper CS; Molina A; Cox ME; Terstappen LW; de Bono JS
    Cancer Res; 2009 Apr; 69(7):2912-8. PubMed ID: 19339269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating tumor cells are transcriptionally similar to the primary tumor in a murine prostate model.
    Helzer KT; Barnes HE; Day L; Harvey J; Billings PR; Forsyth A
    Cancer Res; 2009 Oct; 69(19):7860-6. PubMed ID: 19789350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the hormone receptor status of circulating tumor cell subpopulations based on epithelial-mesenchymal transition: a proof-of-principle study on the heterogeneity of circulating tumor cells.
    Guan X; Ma F; Liu S; Wu S; Xiao R; Yuan L; Sun X; Yi Z; Yang H; Xu B
    Oncotarget; 2016 Oct; 7(40):65993-66002. PubMed ID: 27602758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.